We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-14.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$68.5B
AUM Growth
-$9.16B
Cap. Flow
+$4.06B
Cap. Flow %
5.93%
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,433
Reduced
285
Closed
282

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$124M
2
AAPL icon
Apple
AAPL
+$110M
3
MSFT icon
Microsoft
MSFT
+$104M
4
AMZN icon
Amazon
AMZN
+$71.3M
5
WBD icon
Warner Bros
WBD
+$69.6M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$61.6M
2
CERN
Cerner Corp
CERN
+$50.9M
3
NXPI icon
NXP Semiconductors
NXPI
+$31.4M
4
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$30.4M
5
YUMC icon
Yum China
YUMC
+$16.3M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Healthcare 14.42%
3 Financials 13.45%
4 Consumer Discretionary 10.49%
5 Industrials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUE icon
3126
Cue Biopharma
CUE
$113M
-1,059
Closed -$155K
CURI icon
3127
CuriosityStream
CURI
$159M
-28,398
Closed -$82K
CVAC
3128
DELISTED
CureVac
CVAC
-42,715
Closed -$838K
CVGI icon
3129
Commercial Vehicle Group
CVGI
$148M
-37,176
Closed -$314K
CVM icon
3130
CEL-SCI Corp
CVM
$28.1M
-1,293
Closed -$152K
DAKT icon
3131
Daktronics
DAKT
$1.05B
-48,999
Closed -$188K
DNTH icon
3132
Dianthus Therapeutics
DNTH
$6.15B
-1,564
Closed -$73K
DRIO icon
3133
DarioHealth
DRIO
$75.6M
-769
Closed -$90K
DRRX
3134
DELISTED
DURECT Corp
DRRX
-20,916
Closed -$140K
DTIL icon
3135
Precision BioSciences
DTIL
$191M
-1,655
Closed -$153K
EEX
3136
DELISTED
Emerald Holding
EEX
-30,725
Closed -$104K
ELTX icon
3137
Elicio Therapeutics
ELTX
$82.5M
-1,170
Closed -$25K
EOSE icon
3138
Eos Energy Enterprises
EOSE
$1.43B
-39,877
Closed -$167K
ERNA icon
3139
Eterna Therapeutics
ERNA
$5.09M
-3
Closed -$52K
ESCA icon
3140
Escalade
ESCA
$306M
-13,425
Closed -$177K
ETNB
3141
DELISTED
89bio
ETNB
-11,173
Closed -$42K
FBIO icon
3142
Fortress Biotech
FBIO
$92M
-4,607
Closed -$94K
FDBC icon
3143
Fidelity D&D Bancorp
FDBC
$313M
-4,695
Closed -$218K
FLNT
3144
Fluent
FLNT
$114M
-8,336
Closed -$104K
FORA
3145
DELISTED
Forian
FORA
-12,250
Closed -$85K
FROG icon
3146
JFrog
FROG
$10.1B
-56,791
Closed -$1.53M
FSBW icon
3147
FS Bancorp
FSBW
$321M
-10,048
Closed -$311K
GAN
3148
DELISTED
GAN Ltd
GAN
-48,704
Closed -$235K
GTBP icon
3149
GT Biopharma
GTBP
$10.9M
-536
Closed -$46K
HBIO icon
3150
Harvard Bioscience
HBIO
$27.9M
-3,619
Closed -$225K

Similar funds

RhumbLine Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,433 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.

  • RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
  • RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
  • RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
  • RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
  • RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
  • RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
  • RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.